Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Peripheral B cells from patients with HCV-associated B cell lymphoma exhibit an anergic-like transcriptional profile and evidence of clonal expansion

ABSTRACT: Peripheral B cells from patients with HCV-associated B cell lymphoma exhibit an anergic-like transcriptional profile and evidence of clonal expansion

PROVIDER: PRJNA891217 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21929904_1.fastq.gz	Fastqsanger.gz
	SRR21929904_2.fastq.gz	Fastqsanger.gz
	SRR21929905_1.fastq.gz	Fastqsanger.gz
	SRR21929905_2.fastq.gz	Fastqsanger.gz
	SRR21929906_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 54

Similar Datasets

Peripheral B cells from patients with HCV-associated B cell lymphoma exhibit an anergic-like transcriptional profile and evidence of clonal expansion

Project description:Chronic HCV infection remains a global health concern due to its involvement in hepatic and extrahepatic diseases, including B cell non-Hodgkin’s lymphoma (BNHL). Clinical and epidemiological evidence support a causal role for HCV in BNHL development, although mechanistic insight is lacking. We performed RNA-sequencing on peripheral B cells from patients with HCV, BNHL, and HCV-associated BNHL to identify unique and shared transcriptional profiles associated with transformation. In patients with HCV-associated BNHL, we observed enrichment of an anergic gene signature and evidence of clonal expansion that was correlated with expression of epigenetic regulatory genes. Our data support a role for viral-mediated clonal expansion of anergic-like B cells in HCV-associated BNHL development, and suggest epigenetic dysregulation as a potential mechanism driving expansion. We propose epigenetic mechanisms may be involved in both HCV-associated lymphoma and regulation of B cell anergy, representing an attractive target for clinical interventions.

2022-10-22 | GSE215876 | GEO

TLR9 Stimulation of Anergic HCV-Associated Clonal Memory B Cells Triggers Rheumatoid Factor Autoimmunity by the TNF-α Pathway

Project description:Transcriptionnal analysis of pathogenic IgM Memory B cells stimulated or not with CpG from 3 differents HCV related Cryoglobulinemia.

2019-07-11 | GSE114357 | GEO

TLR9 Stimulation of Anergic HCV-Associated Clonal Memory B Cells Triggers Rheumatoid Factor Autoimmunity by the TNF-α Pathway

Project description:TLR9 Stimulation of Anergic HCV-Associated Clonal Memory B Cells Triggers Rheumatoid Factor Autoimmunity by the TNF-α Pathway

| PRJNA471069 | ENA

Transcription profiling of mouse Th1 T cell clone and anergic Th1 T cell clone made anergic by plate-bound anti-CD3 antibody

Project description:compare gene expression profiles between normal and anergic T cells and identify upregulated genes in anergic T cells Experiment Overall Design: RNA from normal Th1 T cell clone and anergic Th1 T cell clone made anergic by plate-bound anti-CD3 antibody were isolated and amplified for microarray analysis

2008-06-14 | E-GEOD-5960 | biostudies-arrayexpress

Early T follicular helper cell activity accelerates HCV-specific B cell expansion

Project description:Early appearance of neutralizing antibodies during acute hepatitis C virus (HCV) infection is associated with spontaneous viral clearance. However, the longitudinal changes in antigen-specific memory B cell (MBC) responses associated with divergent HCV infection outcomes remain undefined. We characterized longitudinal changes in E2 glycoprotein-specific MBCs from subjects that either spontaneously resolved acute HCV infection or progressed to chronic infection using single cell RNA-seq and functional assays. HCV-specific antibodies in plasma from chronically infected subjects recognized multiple E2 genotypes, while those from spontaneous resolvers exhibited variable cross-reactivity to heterotypic E2. E2-specific MBCs from spontaneous resolvers peaked early after infection (4–6 months), following expansion of activated circulating T follicular helper cells (cTfh) expressing interleukin 21. In contrast, E2-specific MBCs from chronically infected subjects, enriched in VH1-69, expanded during persistent infection (> 1 year), in the absence of activated cTfh expansion. Early E2-specific MBCs from spontaneous resolvers produced monoclonal antibodies (mAbs) with fewer somatic hypermutations and lower E2 binding but similar neutralization as mAbs from late E2-specific MBCs of chronically infected subjects. These findings indicate that early cTfh activity accelerates expansion of E2-specific MBCs during acute infection, which might contribute to spontaneous clearance of HCV.

2021-10-24 | GSE157447 | GEO

Gene expression of control and anergic CD4+ T cells in the mouse

Project description:Anergic T cells are unable to respond to antigen though their TCR is specific for it. Chronic infections and cancer can induce a dsyfunctional immune response which cannot clear the cause of disease. We asked in how far anergic T cells are similar to antigen-exhausted ones.

2020-12-18 | GSE143738 | GEO

HIV/HCV co-infection proteomics

Project description:Hepatic complications of HCV infection, including fibrosis and cirrhosis are accelerated in HIV-infected individuals. Although liver biopsy remains the gold standard for staging HCV-associated liver disease, this test can result in serious complications and is subject to sampling error. These challenges have prompted a search for non-invasive methods for liver fibrosis staging. To this end, we compared serum proteome profiles at different stages of fibrosis in HIV/HCV co- and HCV mono-infected patients using SELDI-TOF MS.

2018-04-09 | PXD009007 | Pride

Gene expression profiles of tumor-induced pTregs and anergic tumor-specific CD4+ T cells

Project description:Up to now the role of tumor-specific pTregs and anergic cells during tumor development is not fully understood. Here we used a genetically-induced tumor expressing a MHC-II restricted DBY model antigen to characterize the tumor-induced pTregs and anergic cells that arise early during tumor development.

2018-04-26 | GSE113624 | GEO

Digital Gene Expression profiles analysis of patients with HCV-related hepatic fibrosis

Project description:Hepatitis C virus (HCV) infection is an important etiology of chronic liver disease. Multiple possible molecular mechanisms were involved in the progression of liver fibrosis in chronically HCV-infected patients. Therefore, the further revealing novel genes for regulating liver fibrosis might provide evidence for gene diagnosis and molecular-targeted therapy. In this study, we examined the differentially expressed mRNA in plasma samples from the healthy control and patients with HCV-related liver fibrosis, in order to explore the potential predicted and therapeutic target for the development of HCV-related liver fibrosis.

2020-09-10 | GSE154055 | GEO

HCV Study

Project description:HCV Study using NGS

| PRJEB8405 | ENA